Author:
Block Matthew S.,Maurer Matthew J.,Goergen Krista,Kalli Kimberly R.,Erskine Courtney L.,Behrens Marshall D.,Oberg Ann L.,Knutson Keith L.
Funder
Mayo Clinic Ovarian Cancer SPORE
Subject
Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy
Reference41 articles.
1. Cancer statistics, 2011;Siegel;CA Cancer J Clin,2011
2. Ovarian cancer staging: does it require a gynecologic oncologist?;Mayer;Gynecol Oncol,1992
3. Kadija S, Stefanovic A, Jeremic K, Radojevic MM, Nikolic L, Markovic I, Atanackovic J. The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis. Int J Gynecol Cancer 2011. Publish Ahead of Print:10.1097/IGC.1090b1013e318234f318852.
4. Evaluation of he4, ca125, risk of ovarian malignancy algorithm (roma) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass;Karlsen;Gynecol Oncol,2012
5. Comparison of a novel multiple marker assay vs the risk of malignancy index for the prediction of epithelial ovarian cancer in patients with a pelvic mass;Moore;Am J Obstet Gynecol,2010
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献